Changing Adjuvant Breast-Cancer Therapy with a Signal for Prevention
- PMID: 27263869
- DOI: 10.1056/NEJMe1606031
Changing Adjuvant Breast-Cancer Therapy with a Signal for Prevention
Comment on
-
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.N Engl J Med. 2016 Jul 21;375(3):209-19. doi: 10.1056/NEJMoa1604700. Epub 2016 Jun 5. N Engl J Med. 2016. PMID: 27264120 Free PMC article. Clinical Trial.
Similar articles
-
Aromatase inhibitors in premenopausal breast cancer.Lancet Oncol. 2012 Apr;13(4):320-1. doi: 10.1016/S1470-2045(11)70399-0. Epub 2012 Jan 20. Lancet Oncol. 2012. PMID: 22265695 No abstract available.
-
Tamoxifen therapy for patients with breast cancer.Lancet. 2013 Jun 15;381(9883):2077-8. doi: 10.1016/S0140-6736(13)61236-2. Lancet. 2013. PMID: 23769223 No abstract available.
-
New trials highlight breast cancer therapy and prevention.JAMA. 2014 Feb 5;311(5):453-4. doi: 10.1001/jama.2013.286122. JAMA. 2014. PMID: 24496521 No abstract available.
-
Adjuvant endocrine therapy in postmenopausal breast cancer patients.Breast. 2005 Dec;14(6):446-51. doi: 10.1016/j.breast.2005.08.003. Epub 2005 Sep 16. Breast. 2005. PMID: 16169728 Review.
-
Extended breast cancer treatment with an aromatase inhibitor (Letrozole) after tamoxifen: why, who and how long?Eur J Obstet Gynecol Reprod Biol. 2006 Jun 1;126(2):146-54. doi: 10.1016/j.ejogrb.2006.03.006. Epub 2006 Apr 18. Eur J Obstet Gynecol Reprod Biol. 2006. PMID: 16621229 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical